4th Quarter - Report

ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.

Firm
Client
Income
—
Expenses
$142,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Corporate Tax Reform

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Securities & Exchange Commission (SEC)

Trade (domestic/foreign) TRD

Japan and China reimbursement and regualtory industry issues

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —

Contacted: SENATE; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES

Manufacturing MAN

Conflict Minerals Regulations

LobbyistCovered position, as disclosed
WHITNEY TULL —

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); SENATE

Health Issues HCR

S. 17, H.R. 436 - Medical Device Tax Repeal H.R. 3209, 3203, 3230, 3205, 3211, 3208, 3206, 3214, 3207, 3204 and S. 1700, 1865, 1943, 1972, 1995 - FDA Policy Physician-owned Distributors

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC)

Bills named: S. 1700 (112th), S. 17 (112th), H.R. 3209 (112th), H.R. 436 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.